Urticaria
73
0
0
44
Key Insights
Highlights
Success Rate
80% trial completion
Published Results
13 trials with published results (18%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
15.1%
11 terminated out of 73 trials
80.0%
-6.5% vs benchmark
30%
22 trials in Phase 3/4
30%
13 of 44 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 44 completed trials
Clinical Trials (73)
A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology
Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria
Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care
Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.
Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares
COrticosteroids in acUte uRticAria in emerGency dEpartment
To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg Orally Dispersible Tablet in Healthy, Adult, Human Subjects Under Fasting Conditions
Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients
A Clinical Study to Assess the Safety and Effectiveness of Utixira Lotion and Utixira Tablet in Healthy Adult Human Subjects With Dry or Sensitive Skin Prone to Mild to Moderate Pruritus and Urticaria
Survey on the Characteristics of Traditional Medicine Syndromes in Urticaria Patients At Le Van Thinh Hospital
GI Symptoms in Infants Fed Goat Milk-based Infant Formula
A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735)
A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)
A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)
An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)
Angioedema Biomarker Research Study
The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment
Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.
The Association Between Human Microbiome and Vitamin D in Chronic Urticaria
Vitamin D Levels in Subjects With Chronic Urticaria and Angioedema